■ CD107a モノクローナル抗体(品番:65050-1-Ig)
図1. CD107a抗体とアイソタイプコントロール抗体を用いた細胞表面マーカー解析
1X10^6 NIH/3T3 cells were intracellularly stained with 0.50 ug Anti-Mouse CD107a (65050-1-Ig, Clone: 1D4B) (red) or 0.50 ug isotype control antibody (blue), and Fluorescein (FITC)-conjugated Affinipure Goat Anti-Rat IgG(H+L) with dilution of 1:1000. Cells were fixed with 90% MeOH.図2. CD107a抗体を用いた免疫蛍光染色結果
Immunofluorescent analysis of (4% PFA) fixed NIH/3T3 cells using 65050-1-Ig (CD107a antibody) at dilution of 1:100 and Rhodamine (TRITC)-conjugated Goat Anti-Rat IgG(H+L).
■ CD107a モノクローナル抗体(品番:FITC-65050)
図1. CD107a抗体とアイソタイプコントロール抗体を用いた細胞表面マーカー解析
1X10^6 NIH/3T3 cells were intracellularly stained with 0.20 ug FITC-Anti-Mouse CD107a antibody (FITC-65050, clone 1D4B) (red) or 0.20 ug FITC-rat IgG2a isotype control (blue). Samples were fixed with 90% MeOH.
■ CD107a モノクローナル抗体(品番:APC-65050)
図1. CD107a抗体を用いた免疫蛍光染色結果
Immunofluorescent analysis of (4% PFA) fixed NIH/3T3 cells using APC-65050 (CD107a antibody) at dilution of 1:100.図2. CD107a抗体とアイソタイプコントロール抗体を用いた細胞表面マーカー解析
1X10^6 NIH/3T3 cells were intracellularly stained with 0.20 ug APC-Anti-Mouse CD107a antibody (APC-65050, clone 1D4B) (red) or 0.20 ug APC-rat IgG2a isotype control (blue). Samples were fixed with 90% MeOH.
■ CD107a モノクローナル抗体(品番:CL488-65050)
図1. CD107a抗体とアイソタイプコントロール抗体を用いた細胞表面マーカー解析
1X10^6 NIH/3T3 cells were intracellularly stained with 5.00 ul CoraLite®488-conjugated Anti-Mouse CD107a (CL488-65050, Clone: 1D4B) (red) or isotype control antibody (blue). Cells were fixed with 90% MeOH.図2. CD107a抗体を用いた免疫蛍光染色結果
Immunofluorescent analysis of (-20°C Ethanol) fixed NIH/3T3 cells using CoraLite®488 CD107a antibody (CL488-65050, Clone: 1D4B ) at dilution of 1:400.
■ CD107a モノクローナル抗体(品番:CL568-65050)
図1. CD107a抗体とアイソタイプコントロール抗体を用いた細胞表面マーカー解析
1X10^6 NIH/3T3 cells were intracellularly stained with 5 ul CoraLite®568 Anti-Mouse CD107a (CL568-65050, Clone: 1D4B) (red), or Control Antibody (blue). Cells were fixed with 4% PFA and permeabilized with 0.1% TritonX-100.図2. CD107a抗体を用いた免疫蛍光染色結果
Immunofluorescent analysis of (-20°C Ethanol) fixed NIH/3T3 cells using CoraLite®568 CD107a antibody (CL568-65050, Clone: 1D4B ) at dilution of 1:100.
■ CD107a モノクローナル抗体(品番:CL594-65050)
図1. CD107a抗体とアイソタイプコントロール抗体を用いた細胞表面マーカー解析
1X10^6 NIH/3T3 cells were intracellularly stained with 5 ul CoraLite®594 Anti-Mouse CD107a (CL594-65050, Clone:1D4B) (red), or Control Antibody. Cells were fixed with 4% PFA and permeabilized with 0.1% TritonX-100.図2. CD107a抗体を用いた免疫蛍光染色結果
Immunofluorescent analysis of (4% PFA) fixed NIH/3T3 cells using CoraLite®594 CD107a antibody (CL594-65050, Clone: 1D4B ) at dilution of 1:100.
■ CD107a モノクローナル抗体(品番:CL647-65050)
図1. CD107a抗体とアイソタイプコントロール抗体を用いた細胞表面マーカー解析
1X10^6 NIH/3T3 cells were intracellularly stained with 5.00 ul CoraLite®647-conjugated Anti-Mouse CD107a (CL647-65050, Clone: 1D4B) (red) or isotype control antibody (blue). Cells were fixed with 90% MeOH.図2. CD107a抗体を用いた免疫蛍光染色結果
Immunofluorescent analysis of (-20°C Ethanol) fixed NIH/3T3 cells using CoraLite®647 CD107a antibody (CL647-65050, Clone: 1D4B ) at dilution of 1:400.